Pinnacle Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Pinnacle Holdings's AZN Position: Q2 2026 in Review
Pinnacle Holdings held its AstraZeneca (AZN) position steady in Q2 2026 at 400 shares worth $75.8K. The position accounts for 0.02% of the portfolio, ranked #171.
Pinnacle Holdings first reported a position in AZN in Q4 2018 and has held it in 29 quarters since. The position peaked at $78.9K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Pinnacle Holdings held 400 shares of AstraZeneca worth $75.8K as of Q2 2026.
- Pinnacle Holdings left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up 0.02% of Pinnacle Holdings's portfolio in Q2 2026, its #171 holding.
- Pinnacle Holdings first reported a position in AstraZeneca in Q4 2018 and has held it in 29 quarters since.
- Pinnacle Holdings's AstraZeneca position peaked at $78.9K in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Pinnacle Holdings's 13F filing for Q2 2026, filed 12 Aug 2026.